PRODIGY PHARMA Trademark

Trademark Overview


On Wednesday, August 28, 2024, a trademark application was filed for PRODIGY PHARMA with the United States Patent and Trademark Office. The USPTO has given the PRODIGY PHARMA trademark a serial number of 98720939. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, July 25, 2025. This trademark is owned by Prodigy Biopharma LLC. The PRODIGY PHARMA trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Marketing services; providing advertising, marketing, and promotional services for the pharmaceutical and medical industry; marketing of telemedicine pharmaceutical preparations to be distributed via compounding pharmacies

Pharmaceutical compounding services not featuring substances containing or derived from cannabis with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis; production of cannabinoid-based pharmaceutical ingredients

Development of pharmaceutical preparations and medicines not containing or derived from cannabis with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis
prodigy pharma

General Information


Serial Number98720939
Word MarkPRODIGY PHARMA
Filing DateWednesday, August 28, 2024
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, July 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesMarketing services; providing advertising, marketing, and promotional services for the pharmaceutical and medical industry; marketing of telemedicine pharmaceutical preparations to be distributed via compounding pharmacies
Goods and ServicesPharmaceutical compounding services not featuring substances containing or derived from cannabis with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis; production of cannabinoid-based pharmaceutical ingredients
NOT AVAILABLEPHARMA
Goods and ServicesDevelopment of pharmaceutical preparations and medicines not containing or derived from cannabis with a delta-9 THC concentration of more than 0.3 percent on a dry weight basis

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2024
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameProdigy Biopharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMiami, FL 33137

Trademark Events


Event DateEvent Description
Wednesday, August 28, 2024NEW APPLICATION ENTERED
Friday, January 17, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 2, 2025NON-FINAL ACTION E-MAILED
Tuesday, March 4, 2025ASSIGNED TO EXAMINER
Tuesday, March 25, 2025ASSIGNED TO EXAMINER
Tuesday, March 25, 2025ASSIGNED TO EXAMINER
Wednesday, April 2, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 2, 2025NON-FINAL ACTION WRITTEN
Monday, June 30, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 25, 2025LETTER OF SUSPENSION E-MAILED
Friday, July 25, 2025NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 25, 2025SUSPENSION LETTER WRITTEN
Tuesday, July 1, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 30, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE